2026 ACG NY DealSource Series: Corporate Strategics Acquirers

Share:
Image
DealMakers DealSource April 2026

Event Details

When:

April 16, 2026 4 PM - 8 PM EDT

Where:
Location Name
To Be Announced

Register Now

Add to Calendar
Event Secondary Body

ACG New York, in partnership with the ACG NY Strategic Acquirers, PE/IB, and Lenders Committees, presents an exclusive DealSource Series event at the New York Athletic Club featuring programming focused on corporate strategic acquisitions. Open to industry-agnostic firms and applicable to dealmakers across the middle market, this highly curated program will include discussions with industry leaders, curated one-on-one deal meetings, and high-value networking in a private club setting, creating an ideal environment to source opportunities, strengthen relationships, and advance transaction activity.

MEETING SELECTIONS OPEN SEVERAL BUSINESS DAYS PRIOR TO THE EVENT
Meeting Schedules will be printed and provided onsite. 

AGENDA:
3:45PM - 4:00PM | Registration & Networking
4:00PM - 5:30PM | Programming (Keynote & Panel)
5:30PM - 5:45PM | Break & General Registration
5:45PM - 7:00PM | One on One Deal Meetings (5 - 15min. Meetings)
7:00PM - 8:00PM | Networking Happy Hour
*Agenda Subject to Modifications

PLEASE NOTE: The Deal Meetings Portion of the event is only open for Fund Managers, Investment Bankers, Lenders and Corporate Strategic Acquirers. You registration may be revoked if you do not comply. 


Hosted by: ACG
Chapter
New York
Share:

Event Materials

Event Materials

Pricing:
$295  ACG Member
$350  Non-Member 

This event is only open for Fund managers, Investment bankers, family offices, LPs, VCs, Independent Sponsors, lenders and Corporate Strategic Acquirers.  Your registration may be nullified. Please contact ACG New York for more information.”

ACG NY In-Person Event Terms & Conditions

A 3% payment processing fee will be added to credit and debit card transactions.  This fee covers non-refundable costs charged by our payment processor and does not represent surplus for ACG.